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ABSTRACT: 
Background 
This study investigates the potential role of herpes simplex virus type 1 (HSV-1) in the 
pathogenesis of neurodegenerative disorders, such as Alzheimer’s disease (AD), by exploring 
changes in gene expression related to antiviral immunity and the autophagic pathway. 
Autophagy is a process that recycles organelles and proteins to create more energy for the cell.  
This pathway has been linked to neurodegeneration, as malfunctions in the completion of this 
process lead to a decline in overall cellular health and function. Interestingly, HSV-1 has been 
shown to block the completion of autophagy, which would potentially contribute to the 
cytopathic changes observed in AD. 
 
Materials & Methods 
Antiviral and autophagy reverse transcriptase, real time PCR (RT2-PCR) microarrays were used 
to analyze changes in gene expression in HSV-1-infected SK-N-MC human neuronal cells 
relative to uninfected cells. Immunofluorescent labeling for lysosomal associated membrane 
protein-1 (LAMP-1) and an autophagosome marker, protein 1 light chain 3 (LC3B), was used to 
determine whether lysosomes and autophagosomes colocalized in SK-N-MC cells after being 
infected with HSV-1.  Labeling of LAMP-1 and LC3B in HSV-1-treated cells was compared to 
that in cells treated with rapamycin (RM) or chloroquine (CQ), known activators of autophagy.  
 
Results 
Genes exhibiting greater than a 2.5-fold increase in mRNA levels in HSV-1-infected SK-N-MC 
cells relative to levels in uninfected cells include genes encoding chemokine ligands (CXCL10, 
CXCL11, CXCL9) and various cytokines (IFNα2, IFNα4, IFNγ, IL1β, IL8, IL15 and TNF). In 
addition, numerous genes associated with autophagy regulation (CASP8, CXCR4, FAS, 
PIK3CG), and autophagosome or autolysosome formation (ATG9B, DRAM1, FAM176A) are 
upregulated.  HSV-infected SK-N-MC cells, as well as RM- or CQ-treated cells, demonstrated 
an increase in labeling for LC3B as compared to uninfected and untreated cells, indicating that 
autophagy was induced.  Lysosome formation, seen as an increase in labeling for LAMP, was 
also increased in infected or treated neuronal cells relative to untreated/uninfected cells, 
especially following treatment with CQ. 
 
Conclusions 
Data reported here demonstrate HSV-1-mediated activation of autophagy within SK-N-MC cells. 
Furthermore, immunofluorescence labeling indicates that while autophagosomes and lysosomes 
are more prevalent in HSV-1-infected SK-N-MC cells, there is little or no colocalization of the 
two structures.  This observation suggests that while autophagy initiation has taken place, the 
autophagic pathway may not go to completion.  Further analysis of the impact of HSV-1 on 
autophagy may suggest a mechanism by which HSV-1 can contribute to some of the pathological 
changes in neurons associated with neurodegeneration. 
 
